EDGAR filings
Every filing EDGAR's full-index lists, from every filer: companies, insiders, funds and filing agents. A search that names no form type, ticker or filer CIK covers at most 31 days and defaults to the last 7.
EDGAR holds what was filed electronically. Electronic filing began in 1993 (the earliest filing here is of 1993-02-11) and was phased in filer by filer until May 1996: filings made on paper before 1993, and during the phase-in by a filer not yet on EDGAR, are not on EDGAR and therefore not here.
50 rows on this page.
| Filed | Form | Filer | Category | 8-K items / description | Accession |
|---|---|---|---|---|---|
| 2019-06-12 | 15-12G |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Other | 0001493152-19-009029 | |
| 2019-06-12 | 8-K |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Current reports | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits | 0001493152-19-009028 |
| 2019-04-02 | NT 10-K |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001493152-19-004682 | |
| 2019-03-06 | 10-Q |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001493152-19-002930 | |
| 2019-03-01 | 10-Q |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001493152-19-002734 | |
| 2019-02-28 | 10-K/A |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001493152-19-002678 | |
| 2019-02-21 | 8-K |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Current reports | 4.01 Changes in Registrant's Certifying Accountant; 9.01 Financial Statements and Exhibits | 0001493152-19-002333 |
| 2019-02-19 | 10-K |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001493152-19-002214 | |
| 2019-02-08 | 10-Q |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001493152-19-001592 | |
| 2019-02-07 | 10-Q |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001493152-19-001537 | |
| 2019-01-31 | 8-K |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Current reports | 1.01 Entry into a Material Definitive Agreement; 1.02 Termination of a Material Definitive Agreement | 0001493152-19-001211 |
| 2018-12-10 | 8-K |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Current reports | 1.01 Entry into a Material Definitive Agreement | 0001493152-18-017221 |
| 2018-11-14 | 8-K |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Current reports | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 7.01 Regulation FD Disclosure | 0001165527-18-000222 |
| 2018-06-05 | SC 14F1 |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Other | 0001165527-18-000098 | |
| 2018-06-05 | 8-K |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Current reports | 3.02 Unregistered Sales of Equity Securities; 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events; 9.01 Financial Statements and Exhibits | 0001165527-18-000097 |
| 2017-08-14 | NT 10-Q |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001165527-17-000174 | |
| 2017-07-13 | 8-K |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Current reports | 3.02 Unregistered Sales of Equity Securities | 0001165527-17-000157 |
| 2017-07-07 | 8-K |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Current reports | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 0001165527-17-000154 |
| 2017-05-19 | 10-Q |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001165527-17-000132 | |
| 2017-05-15 | NT 10-Q |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001551163-17-000095 | |
| 2017-03-31 | 10-K |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001551163-17-000043 | |
| 2016-11-21 | 10-Q |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001551163-16-000549 | |
| 2016-11-14 | NT 10-Q |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001551163-16-000506 | |
| 2016-09-20 | 8-K |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Current reports | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events; 9.01 Financial Statements and Exhibits | 0001551163-16-000481 |
| 2016-09-09 | SC 14F1 |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Other | 0001551163-16-000475 | |
| 2016-08-15 | 10-Q |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001551163-16-000460 | |
| 2016-06-02 | 10-K/A |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001551163-16-000434 | |
| 2016-05-23 | 10-Q |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001551163-16-000419 | |
| 2016-05-16 | NT 10-Q |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001551163-16-000393 | |
| 2016-04-14 | 10-K |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001551163-16-000347 | |
| 2016-03-30 | NT 10-K |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001551163-16-000321 | |
| 2015-12-10 | SC 13G/A |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Ownership | 0001457716-15-000052 | |
| 2015-11-16 | 10-Q |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001551163-15-000271 | |
| 2015-09-08 | 8-K |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Current reports | 3.02 Unregistered Sales of Equity Securities | 0001551163-15-000210 |
| 2015-08-14 | 10-Q |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001551163-15-000194 | |
| 2015-05-15 | 10-Q |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001551163-15-000134 | |
| 2015-04-15 | 10-K |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001551163-15-000098 | |
| 2015-04-01 | NT 10-K |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001551163-15-000067 | |
| 2015-02-06 | SC 13G |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Ownership | 0001193125-15-037335 | |
| 2014-11-17 | 10-Q |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001551163-14-000329 | |
| 2014-11-14 | NT 10-Q |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001551163-14-000326 | |
| 2014-11-12 | 8-K |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Current reports | 8.01 Other Events | 0001551163-14-000310 |
| 2014-10-08 | DEF 14C |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Proxies | 0001551163-14-000282 | |
| 2014-09-26 | PRE 14C |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Proxies | 0001551163-14-000278 | |
| 2014-09-26 | 8-K |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Current reports | 2.01 Completion of Acquisition or Disposition of Assets; 3.03 Material Modification to Rights of Security Holders; 9.01 Financial Statements and Exhibits | 0001551163-14-000277 |
| 2014-08-19 | 10-Q |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001551163-14-000244 | |
| 2014-08-15 | NT 10-Q |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001551163-14-000241 | |
| 2014-05-15 | 10-Q |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001551163-14-000135 | |
| 2014-04-14 | 10-K |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001551163-14-000074 | |
| 2014-04-01 | NT 10-K |
PROTECT PHARMACEUTICAL Corp
CIK 1493526
|
Financial reports | 0001551163-14-000055 |